retatrutide company developer Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Lilly's Retatrutide: Toward the End

No significant heterogeneity was found among RCTs in the diabetic subgroup (I 2 = 0%, P = 0.38), and thus fix-effects model was chosen

Many patients exploring peptide therapy are looking for wellness and recovery support that fits their lifestyle and health goals

Lilly's approach on the other hand, follows a different path: orforglipron is a small molecule that targets the same receptor but was designed for oral administration from the outset

IV delivery eliminates these side effects

Professor Douglas Morrison, one of the scientists behind it, has said the idea is to stimulate appetite-regulating hormones at exactly the right site in the gut

Yes, your GP may prescribe short-term anti-emetic medications such as metoclopramide, prochlorperazine, or cyclizine if nausea and vomiting persist despite lifestyle measures